Investor Presentaiton slide image

Investor Presentaiton

Médica Sur, S.A.B. and Subsidiaries CONSOLIDATED FINANCIAL STATEMENTS December 31, 2016 and 2015 (Mexican pesos) Assets Current Assets: Cash and cash equivalents Notes 2016 2015 Liabilities and Stockholders' Equity Notes 2016 2015 9 $ 104,310,067 359,127,708 Accounts receivable, net 10 Médica Sur Clinical 243,017,165 119,148 162,145,591 214,754 Foundation, A.C. Other accounts receivable 11 72,731,964 4,238,099 Current Liabilities: Loans Suppliers Taxes and accrued expenses Direct employee benefits Inventories, net 12 117,711,083 65,002,000 Provisions for contingent liabilities Prepaid Insurance Assets held for sale 3 (e) 13,874,180 450,668,542 3,702,137 Total current liabilities 17 $ 30,000,000 343,775,705 128,007,863 332,391,347 232,467,170 7,790,238 14,309,432 26 31,228,338 15,791,964 745,185,628 390,576,429 Total current assets 1,002,432,149 594,430,289 Long-term debt, net 17 1,284,297,760 Employee benefits 18 Deferred profit tax 19 31,795,545 90,326,291 12,181,377 125,115,897 Properties, furnishings, equipment 13 2,759,658,229 2,839,239,078 and leasehold improvements, net Investment properties, net 14. 97,335,224 105,267,278 Total liabilities 2,151,605,224 527,873,703 Commercial credit Stockholders' Equity: 16 1,120,216,275 224,016,932 Share capital Contribution for future capital increases Intangible assets, net 6 447,594,046 Other assets, net 31,873,521 8,398,130 Share subscription surplus Accrued earnings Legal reserve Share buy-back reserves Other comprehensive income: Net actuarial profits (losses) from income tax Total equity attributable to controlling interests Non-controlling interests 21 517,869,032 124,628 121,280,931 517,869,032 124,628 121,280,931 2,358,953,976 2,300,441,642 103,573,805 103,573,805 200,000,000 200,000,000 18 1,404,581 (532,389) 3,303,206,953 3,242,757,649 Total Stockholders' Equity Commitments and contingent liabilities 4,297,267 3,307,504,220 720,355 3,243,478,004 26 $ 5,459,109,444 3,771,351,707 See the relevant notes to the Consolidated Financial Statements. 3 4 16 // ANNUAL REPORT $ 5,459,109,444 3,771,351,707 3 5
View entire presentation